Literature DB >> 9618770

Gene therapy of primary immunodeficiencies.

F Candotti1, R M Blaese.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9618770     DOI： 10.1007/bf00792604

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  75 in total

1.  Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments.

Authors:  T Moritz; P Dutt; X Xiao; D Carstanjen; T Vik; H Hanenberg; D A Williams
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

2.  Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.

Authors:  M Noguchi; H Yi; H M Rosenblatt; A H Filipovich; S Adelstein; W S Modi; O W McBride; W J Leonard
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

3.  Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous disease.

Authors:  S Sekhsaria; J I Gallin; G F Linton; R M Mallory; R C Mulligan; H L Malech
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

4.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Authors:  G Dranoff; E Jaffee; A Lazenby; P Golumbek; H Levitsky; K Brose; V Jackson; H Hamada; D Pardoll; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

5.  Expression of human CD18 in murine granulocytes and improved efficiency for infection of deficient human lymphoblasts.

Authors:  R W Wilson; T Yorifuji; I Lorenzo; W Smith; D C Anderson; J W Belmont; A L Beaudet
Journal:  Hum Gene Ther       Date:  1993-02       Impact factor: 5.695

6.  Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.

Authors:  J P DiSanto; W Müller; D Guy-Grand; A Fischer; K Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

7.  CD34+ peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease.

Authors:  F Li; G F Linton; S Sekhsaria; N Whiting-Theobald; J P Katkin; J I Gallin; H L Malech
Journal:  Blood       Date:  1994-07-01       Impact factor: 22.113

8.  Retroviral-mediated gene transfer of the leukocyte integrin CD18 subunit.

Authors:  A L Back; W W Kwok; M Adam; S J Collins; D D Hickstein
Journal:  Biochem Biophys Res Commun       Date:  1990-09-14       Impact factor: 3.575

9.  HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia.

Authors:  C Bonini; G Ferrari; S Verzeletti; P Servida; E Zappone; L Ruggieri; M Ponzoni; S Rossini; F Mavilio; C Traversari; C Bordignon
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

10.  Expression of human adenosine deaminase in mice transplanted with hemopoietic stem cells infected with amphotropic retroviruses.

Authors:  V W van Beusechem; A Kukler; M P Einerhand; T A Bakx; A J van der Eb; D W van Bekkum; D Valerio
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.